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Hepatic Cyst Infection Following Aspiration Sclerotherapy: 
a Case Series 
Titus F.M. Wijnands*, Marten A. Lantinga*, Joost P.H. Drenth
INTRODUCTION
Hepatic cysts are benign, 
fluid-filled cavities located in 
the liver that are estimated 
to occur in 2.5-11.3% of the 
general population [1, 2]. Over 
lifetime, cysts tend to increase in 
volume, leading to mass-related 
symptoms requiring treatment 
[3]. Aspiration sclerotherapy 
(AS) is a minimal-invasive 
treatment option that curtails 
hepatic cyst volume and thereby 
alleviates mass-related symptoms 
[4]. Aspiration sclerotherapy 
is a procedure that comprises 
ultrasonography (US) guided 
percutaneous drainage of the 
hepatic cyst with subsequent 
instillation of a sclerosing agent. 
Sclerotherapy induces lysis of 
secreting cholangiocytes that 
cover the inner cyst wall [5]. e 
literature describes the use of 
many dierent sclerosing agents 
but ethanol is most commonly 
applied as it is effective, safe, 
inexpensive, and widely available 
[6-8]. The most common side 
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effect of AS is pain during or after the procedure [3, 9, 
10]. Other systemic complications include transient fever, 
ethanol intoxication, and pleural eusion [8, 11, 12]. Local 
complications resulting from AS, such as cyst infections, have 
only incidentally been documented. Spontaneous hepatic cyst 
infection is a severe complication that frequently necessitates 
invasive treatment and may even lead to sepsis or death [13, 14].
Over the past ten years we have performed over 250 
AS procedures and encountered a number of hepatic cyst 
infections. is paper highlights ve cases of post-procedural 
hepatic cyst infection to better understand the natural history 
of this complication, in order to provide therapeutical guidance.
CASE 1
A 59-year-old female with a history of polycystic 
liver disease presented with increasing abdominal pain. 
Ultrasonography showed multiple large hepatic cysts and AS 
was suggested in order to reduce mass-related symptoms. 
Without the administration of antibiotic prophylaxis, two large 
hepatic cysts were drained (5 Fr pigtail catheter). e rst cyst 
located posteriorly in the right hepatic lobe contained 800 ml 
of serous uid, the second cyst located anteriorly in the le 
lobe contained 1500 ml of brown, turbid uid. One month 
following the procedure, the patient was seen in the emergency 
room with complaints of right-sided ank pain, fever and chills. 
Laboratory analysis showed an increased serum C-reactive 
protein (CRP) of 100 mg/L (Fig. 1). Ultrasonography revealed 
debris in the anterior hepatic cyst. Under the suspicion of a 
hepatic cyst infection, clindamycin (300 mg three times daily) 
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and ciprooxacin (500 mg twice daily) oral antibiotic therapy 
was initiated (Table I). During the next days, symptoms 
resolved and the patient was discharged. Clindamycin and 
ciprooxacin were continued for a total of six weeks. Two weeks 
aer the stopping of antibiotics, the serum CRP had returned 
to normal (8 mg/L).
CASE 2
A 54-year-old woman with a history of multiple hepatic 
cysts was referred to our outpatient clinic with complaints 
of upper abdominal pain. e largest hepatic cyst (7 cm) 
was located cranially in the right hepatic lobe. Because of 
continuous pain, AS was performed. During the procedure 
the catheter dislocated aer aspiration of 200 ml of clear 
cyst fluid. The intervention was discontinued prior to 
administration of ethanol. Initially, the patient experienced 
a relief of pain. However, three weeks later, upper abdominal 
pain and fever (38.8°C) ensued. Laboratory analysis revealed 
increased serum CRP (107 mg/L) and white blood cell count 
(13.2x109/L). Ultrasonography showed recurrence of the 
treated cyst with internal debris. e patient was admitted and 
treated with intravenous amoxicillin/clavulanic acid antibiotic 
therapy. Aer four days, antibiotic therapy was switched to 
oral moxioxacin for six weeks (400 mg daily). is was 
later switched to ciprooxacin (500 mg twice daily) for four 
additional weeks which led to a resolution of symptoms and 
normalization of serum CRP. 
Fig. 1. Serum C-reactive protein (CRP) in response to antibiotic treatment 
(Cases 1-5). Filled areas correspond with intravenous (dotted) or oral (solid) 
antibiotic therapy.
Table I. Clinical presentation and treatment of post-procedural hepatic cyst infection cases
Case Age/sex Time between AS 
and symptoms
Symptoms Treatment
1 59/F 4 weeks Pain, fever and chills Oral antibiotics 
2 54/F 3 weeks Pain and fever Intravenous and oral antibiotics
3 55/F 3 days Fever and chills Oral antibiotics
4 57/F 3 weeks Pain and fever Intravenous and oral antibiotics
5 69/F 7 weeks Diarrhea, nausea, vomiting and 
subfebrile body temperature
Cyst drainage + intravenous and 
oral antibiotics
AS, aspiration sclerotherapy; F, female
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CASE 3
A 55-year-old Caucasian female with a solitary hepatic 
cyst complained of increased abdominal pain and early 
satiety. A hydatid cyst was excluded during the initial workup. 
Ultrasonography showed a solitary hepatic cyst in the le 
hepatic lobe with a diameter of 18 cm. Aspiration sclerotherapy 
was performed and 2500 ml of clear uid were aspirated. Aer 
the procedure, the patient became febrile (38°C) without 
pain or other complaints. e next day, body temperature 
had normalized and the patient was discharged. ree days 
later, the patient presented with fever (38.5°C) and chills. 
Ciprooxacin (500 mg twice daily) for 14 days was started 
under the suspicion of a cyst infection. Due to a persisting 
elevated serum CRP (68 mg/L), ciprooxacin was continued 
for another 30 days. Although serum CRP remained elevated 
(47 mg/L), ciprooxacin was ultimately stopped. During an 
outpatient clinic visit two months later, the patients’ symptoms 
had resolved and serum CRP had decreased to 10 mg/L.
CASE 4
A 57-year-old woman with polycystic liver disease was 
seen in our outpatient clinic with continuous right ank pain 
since several months. Previous AS treatment of three hepatic 
cysts had led to a successful reduction of cyst volume and 
complaints. Recent computed tomography showed a dominant 
hepatic cyst of 9 cm seated cranially in the right hepatic lobe. 
e patient was therefore again referred for AS. Drainage 
yielded hemorrhagic cyst uid and as active bleeding could not 
be ruled out, sclerosing with ethanol was not performed. ree 
weeks later, the patient presented with upper abdominal pain 
and fever (39.9°C). Laboratory analysis showed an elevated 
serum CRP of 203 mg/L. Blood cultures returned negative. 
18F-FDG PET/CT revealed increased metabolic activity at the 
aspirated hepatic cyst, suggesting cyst infection (Fig. 2). We 
initiated ceriaxone and as the patient rapidly improved we 
switched to oral ciprooxacin. Aer 12 weeks of treatment, 
the patient had completely recovered with normalized CRP 
(5 mg/L).
CASE 5
A 69-year-old female was referred to our clinic because a 
cardiological work-up for chest pain had led to the discovery 
of multiple hepatic cysts. Ultrasonography revealed a large 
cyst (21 cm) located in the right hepatic lobe. During AS, 3000 
ml of clear, yellow uid was drained. Seven weeks later, the 
patient complained of diarrhea (>10 times daily), nausea, and 
vomiting (> 5 times daily). Physical examination revealed right 
and le upper quadrant abdominal tenderness and a subfebrile 
body temperature (38.1°C). Laboratory investigations showed 
a highly increased serum CRP of 374 mg/L. To support the 
diagnosis of a cyst infection in this patient, the recently 
aspirated cyst was punctured with aspiration of pus. A pigtail 
drain (10.5 Fr) was inserted to allow complete drainage of the 
cyst during the following days (Fig. 3). Whereas blood cultures 
remained negative, cyst aspirate culture grew, Klebsiella 
pneumoniae conrming cyst infection diagnosis. Intravenous 
ceriaxone/metronidazole was started. During the next week, 
serum CRP gradually decreased to 68 ml/L. e drain was 
removed and antibiotic therapy was switched to oral treatment 
with ciprooxacin. Aer eight weeks of treatment symptoms 
resolved and serum CRP normalized.
Fig. 2. 18F-FDG PET/CT shows increased metabolic 
activity surrounding the previously aspirated hepatic cyst 
located in the right hepatic lobe (asterisk).
Fig. 3. Computed tomography demonstrating a large hepatic cyst in 
the right hepatic lobe (asterisk) with a pigtail drain inserted.
DISCUSSION
We describe the spectrum of inammatory complications 
of AS that led to the tentative diagnosis of post-procedural 
hepatic cyst infection. All patients presented with acute onset 
abdominal pain and fever three days to seven weeks following 
AS. All patients required hospitalization, received prolonged 
antibiotic therapy (4-10 weeks), and recovered without any 
sequela.
An extensive literature search identied two cases of post-
procedural hepatic cyst infection [12, 15]. ese case reports 
lack diagnostic ndings that support hepatic cyst infection 
diagnosis, such as raised inflammatory markers, positive 
imaging or microbiological ndings. Alternatively, the rise in 
body temperature directly following AS could be the result of 
an inammatory response of the cystic wall, rather than a sign 
of post-procedural infection [16]. Indeed, transient fever is a 
commonly reported side eect [10, 17]. However, both cases 
required intravenous antibiotic treatment [12, 15] suggesting 
a diagnosis of post-procedural hepatic cyst infection.
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e proposed gold standard in diagnosing a cyst infection 
is the presence of a cyst aspirate containing neutrophils and 
pathogens [13]. In absence of a cyst aspirate, a mix of clinical 
and biochemical ndings are used to establish a probable cyst 
infection diagnosis [13]. In hindsight, four out of our ve 
patients were labeled with the diagnosis of probable hepatic cyst 
infection. Treatment of cyst infection is empiric and primarily 
consists of long term antibiotic treatment [18]. In cases of 
failure, invasive strategies such as prolonged cyst drainage or 
even partial hepatectomy have been described as a management 
option [18]. In our experience, prolonged treatment with oral 
ciprooxacin successfully resolved the episode.
To minimize the risk of infection, AS is performed in an 
interventional suite to provide a sterile environment. One hour 
prior to AS we administer cefazolin (intravenous, 1000 mg). 
Dutch guidelines recommend cefazolin, a rst-generation 
cephalosporin, for perioperative prophylaxis [19]. Cefazolin 
is selectively active against micro-organisms most frequently 
isolated from surgical site infections and has a favourable 
plasma-half-life which allows single-dosing. Cefazolin is 
not used as a therapeutic agent [19]. Nonetheless, in our 
series a post-procedural hepatic cyst infection developed 
despite antibiotic prophylaxis. is could be explained by 
an inadequate bactericidal intracystic concentration, as it is 
unknown if cefazolin is able to penetrate into the cyst. Future 
studies investigating the penetration capacity of cefazolin into 
hepatic cysts would be valuable. Alternatively, the antimicrobial 
spectrum of rst-generation cephalosporins might not cover 
the micro-organisms that caused the infection.
CONCLUSION
We presented ve cases with inammatory complications 
following AS, in which a post-procedural hepatic cyst infection 
was suspected. Antibiotic prophylaxis with cefazolin is 
unsuccessful in preventing cyst infection. In cases where a post-
procedural hepatic cyst infection is suspected, we recommend 
pragmatic treatment with ciprooxacin. 
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